- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Healthcare Transactions and Regulatory
Events 15 results
Speaking Engagement
June 2, 2022
Norm Armstrong to Speak at ABA’s Antitrust in Healthcare Conference
Speaking Engagement
April 25, 2022
Tom Hawk to Speak at American Health Law Association’s Healthcare Transactions Conference
Speaking Engagement
February 24, 2022
Tom Hawk, Jen Lewin, Gardner Armsby to Speak at Georgia Society of CPA’s Annual Healthcare Conference
Speaking Engagement
September 29, 2021
Chris Kenny to Speak at Virginia-DC HFMA Fall Education Conference
Speaking Engagement
July 27, 2021
Richard Zall to Speak on Podcast About Legal Ramifications of Mandating Vaccines
Speaking Engagement
May 4, 2021
Craig Carpenito to Speak at American Bar Association Program
Speaking Engagement
April 30, 2021
Craig Carpenito to Speak at California Lawyers Association Program
Speaking Engagement
March 3, 2021
Preeya Noronha Pinto to Speak on FDLI’s Virtual Introduction to Medical Device Law and Regulation Conference
Speaking Engagement
September 21, 2020
Richard Zall to Speak at The Deal Economy: Predictions and Perspectives 2020 Event
Webinar
June 25, 2020
Healthcare M&A in a Post-Pandemic Environment
Webinar
February 27, 2020
CFIUS Reform: Impact on Foreign Investment in Pharmaceutical, Medical Device and Healthcare Companies
Speaking Engagement
January 30, 2020
Torrey McClary to Speak at AHLA’s Academic Medical Centers and Teaching Hospitals Institutions